Yixin Yao

Department of Lymphoma and Myeloma

H指数:23

被引数:2,451

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ROR1 upregulation after CD19-CAR T-cell relapse in mantle cell lymphoma identifies a targetable vulnerability for ROR1-directed bispecific modalities

滤泡性淋巴瘤中CD19-CAR T细胞复发后ROR1上调，为ROR1靶向双特异性模式识别了一种可靶向的脆弱性

Leukemia

IF13.4

2026-10-010

OAAI

CD70-Driven Immunosuppression in Mantle Cell Lymphoma Identifies a Vulnerability to CD70-Directed Bispecific Antibody Modalities

CD70驱动的免疫抑制在套细胞淋巴瘤中确定了CD70定向双特异性抗体模式的易损性

Cancer Letters

IF10.1

2026-09-260

PRE

Reversible and irreversible BTK inhibition promotes stem-like functional multipotency, persistence, and antitumor efficacy of CD19-directed CAR T cells in mantle cell lymphoma

可逆性和不可逆性BTK抑制促进套细胞淋巴瘤中CD19靶向CAR-T细胞的干细胞样功能多能性、持久性和抗肿瘤效果

Leukemia

IF13.4

2026-07-090

OAAI

Correction: Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

更正：将PRMT5作为联合疗法的靶点，用于治疗以ATM和TP53突变频发为特征的套细胞淋巴瘤

Blood Cancer Journal

IF11.6

2026-04-080

OAAI

Integrative profiling strategies to guide personalized therapy in mantle cell lymphoma: a pilot study

整合性分析策略指导套细胞淋巴瘤个性化治疗的初步研究

npj Precision Oncology

IF8

2025-11-210

OAAI

Thin GaN double-channel high electron mobility transistors with AlN back barrier for superior breakdown and transport performance

薄GaN双通道高电子迁移率晶体管，采用AlN背势垒以实现优异的击穿和输运性能

Journal of Alloys and Compounds

IF6.3

2025-10-130

PRE

BCL-2/BCL-XL dual inhibition triggers Gasdermin D-mediated pyroptosis in mantle cell lymphoma

BCL-2/BCL-XL双抑制可触发套细胞淋巴瘤中Gasdermin D介导的焦亡

Cancer Letters

IF10.1

2025-08-030

PREAI

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

TCA循环模式切换决定了套细胞淋巴瘤中耐普拉替诺的持续存在细胞的命运

Blood

IF23.1

2025-07-250

OAAI

Hemodynamic effects of stenosis with varying severity in different segments of the carotid artery using computational fluid dynamics

SCIENTIFIC REPORTS

IF3.9

2025-02-100

OAAI

Investigations of modulation method and stress mechanism for the growth of AlGaN channel heterostructures

对AlGaN沟道异质结构生长的调制方法与应力机制的研究

nanotechnology

IF2.8

2025-01-290

PRE

Cytological analysis of flower development, insights into suitable growth area and genomic background: implications for Glehnia littoralis conservation and sustainable utilization

BMC PLANT BIOLOGY

IF4.8

2024-09-301

OAAI

Ultralow RF Loss for Si-Based GaN Materials with a Variable Power Phosphorus Ion Implantation Method

CRYSTAL GROWTH & DESIGN

IF3.4

2024-05-131

PRE

The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma

hematology oncology

IF13.5

2024-02-072

OAAI

Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins

CELL DEATH & DISEASE

IF9.6

2023-11-023

OAAI

Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma

BLOOD ADVANCES

IF7.1

2023-07-123

OAAI

Expert consensus of management of adverse drug reactions with anaplastic lymphoma kinase tyrosine kinase inhibitors

ESMO OPEN

IF8.3

2023-06-0114

OAAI

Studies on the coupling correlation and strain state of AlGaN/GaN double channel heterostructures grown by metal organic chemical vapor deposition

JOURNAL OF ALLOYS AND COMPOUNDS

IF6.3

2023-05-013

PRE

BTK and MALT1 are critical for cell adhesion and dissemination in mantle cell lymphoma

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

利用PRMT5作为以频繁ATM和TP53突变为特征的套细胞淋巴瘤联合治疗的靶标

BLOOD CANCER JOURNAL

IF11.6

2023-02-1712

OAAI

Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2023-02-0116

OAAI

Yixin Yao

个人简介

教育背景

工作经历

荣誉奖项

研究方向